Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New non-opioid painkiller Journavx approved by FDA
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
12h
on MSN
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
13h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
AFP
19h
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Small plane crashes in Philly
Black boxes recovered
Receives $250K settlement
Boy, 5, dies in explosion
Drone pilot to plead guilty
IL won’t hire Jan. 6 rioters
Apologizes for old tweets
Granted legal personhood
New York doctor indicted
Cause of death revealed
Activists call for boycott
Todd exits NBC News
To again run for Senate?
Tour boat captain sentenced
Seeking a new trial
Walgreens suspends dividend
Ends abortion travel policy
Opens probe into NPR, PBS
Gold hits all-time high
Partners w/ US national labs
Cancerous tumor removed
Ground stop amid IT outage
DOJ sues to block deal
Confirmed interior secretary
FDA approves painkiller
Nashville bids for franchise
Olympic gold medalist dies
Top leaders asked to resign
'As Tears Go By' singer dies
US inflation ticked higher
Recuses self from Act 10 suit
To raise hourly pay
Inmate's transfer blocked
Michigan priest loses license
Feedback